All In Biotech

Free tool

FAERS Monitor: Imitrex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020132 or its brand name (Imitrex, Sumatriptan Succinate). Reports on generic versions are filed under their own applications.

Reports

38,243

Serious

19,164

50% of reports

Hospitalization

7,193

Death reported

909

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective5,506
  • headache3,209
  • nausea2,893
  • migraine2,820
  • fatigue2,169
  • pain2,016
  • dizziness1,727
  • vomiting1,649
  • dyspnoea1,384
  • off label use1,332
  • anxiety1,310
  • diarrhoea1,242
  • arthralgia1,085
  • malaise1,080
  • depression1,058

Reports by year received

View as table
YearReports
2004893
20051,256
2006842
2007851
2008792
2009865
2010798
2011904
20121,153
20131,087
20141,410
20152,197
20162,977
20172,171
20182,645
20193,028
20202,670
20212,165
20222,176
20232,174
20241,888
20251,858
20261,440

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,015,916 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
migraineSignal2,82016.716.140,592
headacheSignal3,2092.82.73,876
depressionSignal1,0582.62.41,015
anxietySignal1,3102.52.41,231
drug ineffectiveSignal5,5062.32.24,312
nauseaSignal2,8932.01.91,528
vomiting1,6491.91.8755
dizziness1,7271.91.8760
pain2,0161.81.7746
fatigue2,1691.51.5417
arthralgia1,0851.41.4146
malaise1,0801.41.3102
dyspnoea1,3841.31.3125
diarrhoea1,2421.11.04
off label use1,3320.80.844

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.